Evidence Hub

Laboratory survey of antibiotic nonsusceptibility among Streptococcus pneumoniae isolates in South Carolina, 1998 versus 2000

Dauner DG, Gibson JJ, Roberts DF, Kotchmar GS

Southern medical journal, 2003

Abstract

BACKGROUND: In 1998, the South Carolina Department of Health and Environmental Control surveyed clinical microbiology laboratories statewide to determine the prevalence of antibiotic nonsusceptibility among isolates of Streptococcus pneumoniae. A follow-up study was conducted in 2001.

METHODS: A cross-sectional study was conducted to estimate the prevalence of penicillin nonsusceptibility (PCN-N), extended-spectrum cephalosporin nonsusceptibility (ESC-N), and levofloxacin nonsusceptibility (LEV-N) in South Carolina. A standardized questionnaire was mailed to 89 laboratories.

RESULTS: The prevalence of penicillin intermediate resistance increased from 1998 (17.6%) to 2000 (20.9%, chi2 P = 0.008). Furthermore, the prevalence of PCN-N increased from 1998 (34.5%) to 2000 (38.4%, chi2 P = 0.01). The prevalence of ECN-N decreased from 1998 (19.1%) to 2000 (17.7%), but the difference was not significant (chi2 P = 0.25).

CONCLUSION: The laboratory survey was a low-cost method of estimating the change in prevalence of antibiotic nonsusceptibility, and it emphasizes regional surveillance because the prevalence of antibiotic nonsusceptibility varied geographically.

How strong is the evidence?

Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free